CINECA IRIS Institutional Research Information System

FORNARO, LORENZO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.300
AS - Asia 958
EU - Europa 505
SA - Sud America 190
AF - Africa 93
Totale 3.046
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.252
SG - Singapore 352
CN - Cina 221
BR - Brasile 151
IT - Italia 146
HK - Hong Kong 131
VN - Vietnam 116
DE - Germania 73
SE - Svezia 69
GB - Regno Unito 53
CI - Costa d'Avorio 50
FR - Francia 35
IN - India 28
FI - Finlandia 24
CA - Canada 21
RU - Federazione Russa 20
TR - Turchia 20
BD - Bangladesh 19
AT - Austria 18
SN - Senegal 18
NL - Olanda 17
AR - Argentina 15
IQ - Iraq 12
ES - Italia 10
MX - Messico 10
JP - Giappone 9
EC - Ecuador 8
LT - Lituania 8
PL - Polonia 8
ID - Indonesia 7
UZ - Uzbekistan 7
NG - Nigeria 6
PK - Pakistan 6
VE - Venezuela 6
BG - Bulgaria 5
KE - Kenya 5
UA - Ucraina 5
ZA - Sudafrica 5
CL - Cile 4
CR - Costa Rica 4
AL - Albania 3
CZ - Repubblica Ceca 3
HN - Honduras 3
MY - Malesia 3
PA - Panama 3
PH - Filippine 3
TN - Tunisia 3
AE - Emirati Arabi Uniti 2
CO - Colombia 2
EG - Egitto 2
IR - Iran 2
JM - Giamaica 2
JO - Giordania 2
KR - Corea 2
PY - Paraguay 2
RO - Romania 2
SA - Arabia Saudita 2
SK - Slovacchia (Repubblica Slovacca) 2
SY - Repubblica araba siriana 2
TH - Thailandia 2
AO - Angola 1
AZ - Azerbaigian 1
BE - Belgio 1
BZ - Belize 1
CH - Svizzera 1
DO - Repubblica Dominicana 1
EE - Estonia 1
ET - Etiopia 1
GD - Grenada 1
GT - Guatemala 1
IL - Israele 1
KG - Kirghizistan 1
KH - Cambogia 1
KZ - Kazakistan 1
LB - Libano 1
MA - Marocco 1
MM - Myanmar 1
MU - Mauritius 1
OM - Oman 1
PE - Perù 1
PS - Palestinian Territory 1
SI - Slovenia 1
TJ - Tagikistan 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
Totale 3.046
Salva come PNG Salva come JPEG
Città #
Ashburn 200
Singapore 191
San Jose 160
Hong Kong 127
Santa Clara 126
Chandler 86
Shanghai 59
Dallas 51
Abidjan 50
New York 45
Los Angeles 39
Munich 38
Florence 32
Boardman 30
Ho Chi Minh City 30
Council Bluffs 29
Hanoi 25
London 25
Beijing 24
Milan 22
Colorado Springs 18
Dakar 18
Fairfield 15
Lauterbourg 15
Lawrence 15
Princeton 15
Vienna 15
Istanbul 14
Redondo Beach 12
Buffalo 11
Helsinki 11
Medford 11
Turku 11
Wilmington 11
Chennai 10
Frankfurt am Main 10
Houston 10
São Paulo 10
Da Nang 9
San Diego 9
Baltimore 8
Kent 8
Montreal 8
Tokyo 8
Baghdad 7
Bremen 7
Haiphong 7
Mexico City 7
Nuremberg 7
Ogden 7
Phoenix 7
Warsaw 7
Denver 6
Düsseldorf 6
Orem 6
Poplar 6
Quanzhou 6
Amsterdam 5
Brooklyn 5
Cascina 5
Curitiba 5
Fuzhou 5
Lagos 5
Pisa 5
Sofia 5
Tashkent 5
Toronto 5
Turin 5
Biên Hòa 4
Boston 4
Bắc Ninh 4
Memphis 4
Portsmouth 4
Seacroft 4
Thái Nguyên 4
Ankara 3
Bexley 3
Chicago 3
Elk Grove Village 3
Hyderabad 3
Hải Dương 3
Manchester 3
Olomouc 3
Panama City 3
Redmond 3
Rome 3
San Francisco 3
San José 3
Stockholm 3
Tirana 3
Vicopisano 3
Vilnius 3
Woodbridge 3
Amman 2
Bacoli 2
Belo Horizonte 2
Bologna 2
Bảo Lộc 2
Campinas 2
Caxias do Sul 2
Totale 1.908
Salva come PNG Salva come JPEG
Nome #
Durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer: A large real-life worldwide population 134
Association of NOS3 and ANGPT2 gene polymorphisms with survival in patients with hepatocellular carcinoma receiving sorafenib: Results of the multicenter prospective INNOVATE study 134
Early increase of plasma soluble VEGFR-2 is associated with clinical benefit from second-line treatment of paclitaxel and ramucirumab in advanced gastric cancer 120
Different Genomic Clusters Impact on Responses in Advanced Biliary Tract Cancer Treated with Cisplatin Plus Gemcitabine Plus Durvalumab 119
The prognostic nutritional index predicts survival and response to first-line chemotherapy in advanced biliary cancer 118
Cholangiocarcinoma: new perspectives for new horizons 117
Glycolytic competence in gastric adenocarcinomas negatively impacts survival outcomes of patients treated with salvage paclitaxel-ramucirumab 115
A prognostic model in patients with advanced biliary tract cancer receiving first-line chemotherapy 113
Durvalumab Plus Gemcitabine and Cisplatin Versus Gemcitabine and Cisplatin in Biliary Tract Cancer: a Real-World Retrospective, Multicenter Study 112
Prognostic Role of a New Index Tested in European and Korean Advanced Biliary Tract Cancer Patients: the PECS Index 112
Prediction of survival with second-line therapy in biliary tract cancer: Actualisation of the AGEO CT2BIL cohort and European multicentre validations 110
Selecting patients for gastrectomy in metastatic esophago-gastric cancer: Clinics and pathology are not enough 109
Impact of Baseline Characteristics on the Overall Survival of HCC Patients Treated with Sorafenib: Ten Years of Experience 107
Clinical insights and prognostic factors from an advanced biliary tract cancer case series: a real-world analysis 105
Effects of Metformin and Vitamin D on Clinical Outcome in Cholangiocarcinoma Patients 103
Long-term survival after liver metastasectomy in gastric cancer: Systematic review and meta-analysis of prognostic factors 102
Concordance of PD-L1 status in primary gastroesophageal adenocarcinoma and matched peritoneal metastases: a single institution study 101
Combination chemotherapy in patients with advanced pancreatic cancer with an eastern cooperative oncology group performance status of 2: Lights and shadows of a frail route 101
Network meta-analysis of adjuvant chemotherapy in biliary tract cancers: Setting the scene for new randomized evidence 100
FOLFIRINOX Adjuvant Therapy for Pancreatic Cancer 91
Platinum sensitivity in patients with IDH1/2 mutated vs wild-type intrahepatic cholangiocarcinoma: A propensity score-based study 84
Validated clinico-pathologic nomogram in the prediction of HER2 status in gastro-oesophageal cancer 81
Second-line chemotherapy in advanced biliary cancer: The present now will later be past 79
Concordance of microsatellite instability and mismatch repair status in paired biopsies and surgical specimens of resectable gastroesophageal adenocarcinoma: time for a call to action 78
Surgery and Hyperthermic Intraperitoneal Chemotherapy for Gastric Cancer With Peritoneal Carcinomatosis: The Need for Clear Answers Through Proper Questions 75
Regret affects the choice between neoadjuvant therapy and upfront surgery for potentially resectable pancreatic cancer 73
Evolving Landscape in Liver Transplantation for Hepatocellular Carcinoma: From Stage Migration to Immunotherapy Revolution 69
Impact of Antibiotic Therapy in Patients with Cholangiocarcinoma Treated with Chemoimmunotherapy 45
The impact of molecular alterations in patients with advanced biliary tract cancer receiving cisplatin, gemcitabine, and durvalumab: a large, real-life, worldwide population 44
Genomically matched therapy in advanced solid tumors: the randomized phase 2 ROME trial 43
Negative impact of corticosteroid use on outcome in patients with advanced BTCs treated with cisplatin, gemcitabine, and durvalumab: A large real‐life worldwide population 39
Genomic pathway alterations and their prognostic impact in biliary tract cancer: Insights from a multinational cohort treated with cisplatin, gemcitabine, and durvalumab 35
A Prognostic Index for Advanced Biliary Tract Cancer Treated With Cisplatin, Gemcitabine and Durvalumab: The MAGIC‐D Index 34
Durvalumab in Advanced Biliary Tract Cancer: Real‐World Data From a Large Cohort of Patients Across Multiple International Centers 33
Association of candidate surrogate endpoints with overall survival in advanced biliary tract cancer 32
The Impact of Concordance between Liquid and Tissue Biopsy for Actionable Mutations: Insights from the ROME Trial 18
The role of the molecular tumor board: learnings from the ROME trial 13
Totale 3.098
Salva come PNG Salva come JPEG
Categoria #
all - tutte 11.147
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.147
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022112 0 0 0 0 0 44 0 4 2 19 15 28
2022/2023348 30 62 27 10 35 30 1 30 84 1 32 6
2023/2024150 9 14 22 4 20 20 15 0 6 3 17 20
2024/2025935 5 52 32 51 86 143 43 46 89 97 117 174
2025/20261.531 112 133 114 178 158 119 245 113 79 179 68 33
2026/202722 22 0 0 0 0 0 0 0 0 0 0 0
Totale 3.098